NIH supports milestone-driven development of non-addictive small molecule and biologic pain treatments, from lead optimization through Phase I testing, to prepare candidates for Phase II trials.
Funding for research developing non-addictive pain treatments through early drug discovery to support the Pain Therapeutics Development Program.
This grant supports interdisciplinary research to understand how non-addictive natural products manage chronic pain through holistic, multisystem approaches, aiming to develop safe, evidence-based pain relief strategies.
This grant funds research to speed up the use of proven addiction prevention, treatment, and recovery methods for opioid and overdose crises, focusing on scalable, evidence-based solutions at multiple levels.
This grant supports clinical trials and research to improve pain management, addiction treatment, anesthesia safety, and drug prescribing practices.
NIH seeks a single center to coordinate research, build capacity, assess barriers, and develop resources supporting integrated care for chronic pain and opioid use disorder; clinical trials are not allowed.